Israel’s MeMed (see here previously) has been awarded nearly $727,800 from the US Biomedical Advanced Research and Development Authority (BARDA) to support a trial of its 15-minute MeMed BV test that distinguishes between bacterial and viral infections.

https://www.me-med.com/press_release/memed-awarded-us-barda-contract/